IBJNews

New rules raise stakes for Lilly drug

Back to TopCommentsE-mailPrintBookmark and Share

Drugmakers—including Eli Lilly and Co.—testing experimental Alzheimer’s medicines got good news last week when the National Institute on Aging and the Alzheimer’s Association proposed new guidelines to make earlier diagnoses of the disease.

If adopted, those guidelines—along with new forms of testing for Alzheimer’s—are expected to triple the prevalence of the disease, which now stands at 5.3 million Americans, according to the Deloitte Center for Health Solutions.

That’s great if you’re trying to sell a product to that market, as drugmakers are clamoring to do. They have more than 100 experimental Alzheimer’s medicines in human testing right now, according to The New York Times.

Lilly can claim four of those, including two in Phase 3 clinical trials, the last stage before seeking market approval from the U.S. Food and Drug Administration.Those late-stage drugs attempt to block or reduce levels of protein plaques in the brain, called amyloid beta, which are thought to cause the telltale memory loss of Alzheimer’s.

But there is a problem, the Times noted in a July 16 story. The FDA says it needs to know not just that a drug reduced or even eliminated amyloid plaque, but also that patients taking the drug experienced better memory and clearer thinking. But with a slow-progressing disease like Alzheimer’s, the time it would take to document such changes could make testing too expensive for drug companies.

That’s especially the case for Lilly, which is hoping a breakthrough Alzheimer’s drug might produce the kind of blockbuster sales it needs to offset the loss of revenue from its antispychotic drug Zyprexa, which will lose its protection against cheap generic copies in October 2011.

Current medicines give only temporary relief of the symptoms of Alzheimer's, but do not appear to slow progression of the disease. That's why, even before the new recommended guidelines were announced, Barcalys Capital analyst Tony Butler predicted an Alzheimer’s drug that actually prevents or reverses the disease could fetch sales of $5 billion a year, according to Bloomberg News.

That’s roughly the amount of revenue Lilly stands to lose from its schizophrenia drug Zyprexa—and the company has few other drug candidates near enough to market approval to fill in that looming revenue gap.

ADVERTISEMENT

  • New rules
    *New rules* includes the level playing field of the Internet.The World Wide Web enables the little guy whistle-blowers to inform on any company malfeasance,such was Zyprexa.

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. I am not by any means judging whether this is a good or bad project. It's pretty simple, the developers are not showing a hardship or need for this economic incentive. It is a vacant field, the easiest for development, and the developer already has the money to invest $26 million for construction. If they can afford that, they can afford to pay property taxes just like the rest of the residents do. As well, an average of $15/hour is an absolute joke in terms of economic development. Get in high paying jobs and maybe there's a different story. But that's the problem with this ask, it is speculative and users are just not known.

  2. Shouldn't this be a museum

  3. I don't have a problem with higher taxes, since it is obvious that our city is not adequately funded. And Ballard doesn't want to admit it, but he has increased taxes indirectly by 1) selling assets and spending the money, 2) letting now private entities increase user fees which were previously capped, 3) by spending reserves, and 4) by heavy dependence on TIFs. At the end, these are all indirect tax increases since someone will eventually have to pay for them. It's mathematics. You put property tax caps ("tax cut"), but you don't cut expenditures (justifiably so), so you increase taxes indirectly.

  4. Marijuana is the safest natural drug grown. Addiction is never physical. Marijuana health benefits are far more reaching then synthesized drugs. Abbott, Lilly, and the thousands of others create poisons and label them as medication. There is no current manufactured drug on the market that does not pose immediate and long term threat to the human anatomy. Certainly the potency of marijuana has increased by hybrids and growing techniques. However, Alcohol has been proven to destroy more families, relationships, cause more deaths and injuries in addition to the damage done to the body. Many confrontations such as domestic violence and other crimes can be attributed to alcohol. The criminal activities and injustices that surround marijuana exists because it is illegal in much of the world. If legalized throughout the world you would see a dramatic decrease in such activities and a savings to many countries for legal prosecutions, incarceration etc in regards to marijuana. It indeed can create wealth for the government by collecting taxes, creating jobs, etc.... I personally do not partake. I do hope it is legalized throughout the world.

  5. Build the resevoir. If built this will provide jobs and a reason to visit Anderson. The city needs to do something to differentiate itself from other cities in the area. Kudos to people with vision that are backing this project.

ADVERTISEMENT